Thalys Medical Technology Group Corporation (SHA:603716)
China
· Delayed Price · Currency is CNY 23.63
-0.27 (-1.13%)
Mar 10, 2026, 11:29 AM CST
SHA:603716 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 9, 2026 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Market Capitalization | 4,929 | 1,350 | 2,126 | 2,115 | 2,800 | 3,265 | Upgrade
|
| Market Cap Growth | 179.19% | -36.50% | 0.51% | -24.45% | -14.23% | -5.78% | Upgrade
|
| Enterprise Value | 5,334 | 2,305 | 3,163 | 3,337 | 3,959 | 4,036 | Upgrade
|
| Last Close Price | 23.90 | 7.22 | 11.09 | 11.04 | 14.39 | 16.47 | Upgrade
|
| PE Ratio | - | - | - | - | - | 56.72 | Upgrade
|
| Forward PE | - | 35.82 | 35.82 | 35.82 | 35.82 | 35.82 | Upgrade
|
| PS Ratio | 3.95 | 0.75 | 1.06 | 0.92 | 1.08 | 1.54 | Upgrade
|
| PB Ratio | 4.68 | 1.40 | 1.62 | 1.41 | 1.61 | 1.81 | Upgrade
|
| P/TBV Ratio | 4.85 | 1.57 | 2.00 | 1.72 | 2.04 | 2.24 | Upgrade
|
| P/FCF Ratio | 82.47 | 17.68 | 25.00 | - | - | - | Upgrade
|
| P/OCF Ratio | 66.16 | 13.56 | 16.89 | 75.23 | - | 328.31 | Upgrade
|
| EV/Sales Ratio | 4.28 | 1.27 | 1.58 | 1.45 | 1.52 | 1.90 | Upgrade
|
| EV/EBITDA Ratio | - | 48.74 | 94.19 | 73.79 | 23.73 | 16.09 | Upgrade
|
| EV/EBIT Ratio | - | 179.00 | - | - | 41.75 | 23.15 | Upgrade
|
| EV/FCF Ratio | 89.25 | 30.18 | 37.19 | - | - | - | Upgrade
|
| Debt / Equity Ratio | 0.56 | 0.96 | 0.80 | 0.94 | 0.92 | 0.78 | Upgrade
|
| Debt / EBITDA Ratio | - | 14.48 | 18.82 | 20.41 | 8.37 | 5.57 | Upgrade
|
| Debt / FCF Ratio | 9.78 | 12.11 | 12.34 | - | - | - | Upgrade
|
| Net Debt / Equity Ratio | 0.42 | 0.74 | 0.59 | 0.68 | 0.64 | 0.41 | Upgrade
|
| Net Debt / EBITDA Ratio | -6.98 | 15.12 | 22.97 | 22.34 | 6.68 | 2.94 | Upgrade
|
| Net Debt / FCF Ratio | 7.42 | 9.37 | 9.07 | -38.10 | -5.75 | -6.26 | Upgrade
|
| Asset Turnover | 0.48 | 0.59 | 0.55 | 0.56 | 0.63 | 0.62 | Upgrade
|
| Inventory Turnover | 3.79 | 4.44 | 4.24 | 4.21 | 4.75 | 4.36 | Upgrade
|
| Quick Ratio | 1.08 | 1.23 | 1.42 | 1.32 | 1.53 | 1.75 | Upgrade
|
| Current Ratio | 1.38 | 1.52 | 1.72 | 1.61 | 1.87 | 2.11 | Upgrade
|
| Return on Equity (ROE) | -21.75% | -16.99% | -11.15% | -11.74% | -2.17% | 4.79% | Upgrade
|
| Return on Assets (ROA) | -2.02% | 0.26% | -0.32% | -0.24% | 1.44% | 3.15% | Upgrade
|
| Return on Invested Capital (ROIC) | -5.52% | 0.68% | -0.82% | -0.58% | 3.51% | 5.87% | Upgrade
|
| Return on Capital Employed (ROCE) | -7.80% | 0.90% | -1.00% | -0.70% | 3.70% | 6.90% | Upgrade
|
| Earnings Yield | -4.88% | -15.50% | -7.46% | -7.27% | -1.77% | 1.76% | Upgrade
|
| FCF Yield | 1.21% | 5.66% | 4.00% | -1.25% | -6.92% | -3.61% | Upgrade
|
| Payout Ratio | - | - | - | - | - | 103.03% | Upgrade
|
| Buyback Yield / Dilution | 4.89% | 0.73% | 0.62% | 1.73% | 0.23% | -0.66% | Upgrade
|
| Total Shareholder Return | 4.89% | 0.73% | 0.62% | 1.73% | 0.23% | -0.66% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.